How Profitable Are The COVID-19 Vaccines?

How Profitable Are The COVID-19 Vaccines?

How Profitable Are COVID-19 Vaccines?(continued from Why Are Prescription Drugs So Expensive?)

How profitable are the COVID-19 vaccines?

Each dose of Pfizer's COVID-19 vaccine costs "76 pence" (source), equal to $1.00, to manufacture. Pfizer's Chief Financial Officer (CFO) Frank D'Amelio told investors during the company's February 2, 2021 earnings call that once Pfizer's vaccine has gained market acceptance, he expects it to eventually be priced at "150, 175 dollars per dose" (source).

Roughly 60%, 25% and 15% of the world's 7.8 billion people live in low-, middle- and high-income countries, respectively. If the eventual gross profit per dose for all COVID-19 vaccines is conservatively estimated to be $14, $59 and $149 from low-, middle- and high-income countries, respectively, and if everyone gets 3 doses per year, the combined gross profit for the vaccine makers will be $1.07 trillion ($1,070,000,000,000) per year:


Countries
Percent
of Total
Billion
People
Profit
/Dose
Doses
 /Year
Gross Profit
/Year
Low Income 60% 4.68 $14 3 $197 billion
Middle Income 25% 1.95 $59 3 $345 billion
High Income 15% 1.17 $149 3 $523 billion
TOTAL 100% 7.80     $1.07 trillion
           

If the vaccine makers spend another $2 per dose to distribute the 23.4 billion doses, bribe government officials and doctors, etc. (see Big Pharma Corruption), their combined net profit will be $1.02 trillion per year, which at a price-to-earnings (P/E) ratio of 20, will raise their combined market valuation by $20.4 trillion ($20,400,000,000,000).

The combined market valuation of Apple, Microsoft, Alphabet, Amazon and Facebook is less than half of that today.

"For the love of money is a root of all kinds of evil, for which some have strayed from the faith in their greediness, and pierced themselves through with many sorrows."
1 Timothy 6:10